FDA Recall
Terminated
Historical recordClass II
MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass II
MIDAZolam HCl 0.1 mg/mL in 5% DEXTROSE 2.5 mL syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999993721
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass II
Midazolam HCl in 0.9% Sodium Chloride Injection, 0.5 mg/mL 1 mL (0.5 mg/mL), 1 mL syringes, Rx Only, Cantrell Drug Co., Little Rock AR --- NDC 52533-157-45, UPC: 0100352533157455
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass II
LIDocaine HCl 1% BUFFERED WITH SODIUM BICARBONATE Injection, packaged in 3 mL Syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992033
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass II
HEPARIN Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL), Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-148-16, UPC: 0100352533148163
by Cantrell Drug Company
- Reason
- Stability Data Does Not Support Expiry
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass II
HEParin Sodium 0.5 USP UNITS/mL in 0.225% SODIUM CHLORIDE, in 3 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992212
by Cantrell Drug Company
- Reason
- Stability Data Does Not Support Expiry
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
fentaNYL Citrate 50 mcg/mL in Sterile Water for Injection, packaged in 2 mL syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-074-16, UPC: 0100352533074165
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
fentaNYL CITRATE 4 MCG/mL in 0.9% SODIUM CHLORIDE Injection, in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999993491
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
fentaNYL CITRATE 25 mcg/mL in 5% DEXTROSE Injection, in 2 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock AR --- UPC: 9999993301
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
fentaNYL Citrate 1 MCG/mL in 0.9% Sodium Chloride Injection, in 3 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992131
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
fentaNYL citrate in 0.9% Sodium Chloride Injection, 10 mcg/1 mL (10 mcg/mL), in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-024-45, UPC: 0100352533024450
by Cantrell Drug Company
- Reason
- Subpotent Drug
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
ZI XIU TANG BEAUTY FACE & FIGURE Capsules, 250 mg, 60-count bottles
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
XCEL ADVANCED Capsules, 350mg, 60-count bottles, Manufactured for JNS Health
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
XCEL Capsules, 300 mg, 60-count bottles, Manufactured for JNS Health
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared fluoxetine, an FDA approved drug used to treat depression, anxiety, panic attacks, obsessive-compulsive disorder, or bulimia and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
Ultimate Formula Capsules, 250mg, 48-count bottles, Manufactured for: Zi Xiu Tang Success, LLC Trexlertown, PA 18087, USA www.zixiutangsuccess.com
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
SLIM TRIM U Capsules, 250mg, 60-count bottles, Manufactured for Floyd Nutrition
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
SlimeX-15 Capsules, 15 mg, 30-count bottles, Marketed by: Signature Pharmaceuticals Ltd. MUMBAI-400-030 Manufactured in India by: HAB Pharmaceuticals & Research Limited 10-Pharma City, SIDCUL, Selaqui, Dehradun, 248 197
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass I
Prime Capsules, 500mg, 60-count bottles, Distributed By Zagonfly 3129 25th St. #392 Columbus, IN 47203
by Bee Extremely Amazed LLC
- Reason
- Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.
- Published
- July 13, 2016
- Distribution
- Nationwide
View recall →
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions.
Read the full medical disclaimer.